Moderna (MRNA) Misses Q1 EPS by $1.38, Beats on Revenue
Tweet
Share
E-mail
Get Alerts MRNA Hot Sheet
Join SI Premium – FREE
Moderna (NASDAQ: MRNA) reported Q1 EPS of ($3.40), $1.38 worse than the analyst estimate of ($2.02). Revenue for the quarter came in at $389 million versus the consensus estimate of $251.76 million.
For earnings history and earnings-related data on Moderna (MRNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- JPMorgan Assumes Kanzhun Ltd. (BZ) at Overweight
- Morgan Stanley Downgrades Repsol SA (REP:SM) (REPYY) to Equalweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
